17856-4070Level 3
Phenytoin (Phenytoin)
**Product type:** Human Prescription Drug
**Active ingredient:** PHENYTOIN
**Strength:** 125 mg/5mL
**Dosage form:** Suspension
**Route:** Oral
**Labeler:** ATLANTIC BIOLOGICALS CORP.
**Marketing category:** ANDA (ANDA040521)
**Pharmacologic class:** Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
GET
/api/v1/systems/ndc_fda/nodes/17856-4070Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.